Xavier Liogier

Xavier Liogier

Company: Loulou Foundation

Job title: Chief of Translational Science

Seminars:

Panel Discussion – How Can We Gain Consensus on Developing Patient Centric Outcome Measures for Rare Neurodevelopmental Indications? 11:00 am

Read more

day: Day Two

Leveraging Natural History Studies in Clinical Trial Design for Rare CNS and Neurodevelopmental Disorders 8:00 am

Despite common traits and symptoms, each NDD displays a high variability in their phenotype (e.g. ASD, Down syndrome, Rett syndrome, CDD) Characterizing this disease variability together with potential endpoints evaluation is critical before embarking into drug development Exploring case studies of how observational / natural history studies in NDD helped to improve early and late…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.